Clinical trial
Hematopoietic Stem Cell Support in Vasculitis
NCT00278512 · Northwestern University, Other · Terminated
Key facts
| NCT number | NCT00278512 |
|---|---|
| Title | Hematopoietic Stem Cell Support in Vasculitis |
| Official title | High Dose Immune Suppression With Hematopoietic Stem Cell Support in Refractory Vasculitis, Necrotizing Vasculitis, Neurovascular Behcet's Disease, and Sjogren's Syndrome |
| Lead sponsor | Northwestern University, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Vasculitis |
| Intervention type | Biological, Drug |
| Interventions | Autologous Stem Cell Transplant, Allogeneic Stem Cell Transplant, Cyclophosphamide, ATG (rabbit), G-CSF, Campath-1h, Fludarabine, Tacrolimus, Mesna |
| Enrollment | 7 |
| Start date | Aug 1, 2003 |
| Primary completion | Jun 1, 2016 |
| Completion | Jun 1, 2016 |
| First posted | Jan 18, 2006 |
| Last update posted | Aug 2, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: